Diagnostic criteria for depression in type 2 diabetes: A data-driven approach

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Starkstein, Sergio E ^b   Davis, Wendy A ^a   Dragovic, Milan ^b   Cetrullo, Violetta ^a   Davis, Timothy M E ^a   Bruce, David G ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; INSULIN; PSYCHOTROPIC AGENT;

ADULT; ANXIETY; ARTICLE; BRIEF LIFETIME DEPRESSION SCALE; CONTROLLED STUDY; DEPRESSION; DIABETIC PATIENT; DRUG USE; DSM-5; DSM-IV; FEMALE; GENERALIZED ANXIETY DISORDER SCALE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PATIENT CODING; PATIENT HEALTH QUESTIONNAIRE 9; PROBABILITY; SYMPTOM; AGED; AUSTRALIA; COMPLICATION; DEPRESSIVE DISORDER, MAJOR; MIDDLE AGED; PSYCHOLOGY; PSYCHOMETRY; QUESTIONNAIRE; STATISTICAL MODEL; TREATMENT OUTCOME;

AGED; ANXIETY; AUSTRALIA; DEPRESSION; DEPRESSIVE DISORDER, MAJOR; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MODELS, STATISTICAL; PROBABILITY; PSYCHOMETRICS; QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 84911487890     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0112049     Document Type: Article

References (26)

1. Blay SL, Fillenbaum GG, Marinho V, Andreoli SB, Gastal FL (2011) Increased health burden associated with comorbid depression in older Brazilians with diabetes. J Affect Disord. 134(1-3): 77-84.
2. Gonzalez JS, Peyrot M, McCarl LA, Collins EM, Serpa L, et al (2008) Depression and diabetes treatment nonadherence: a meta-analysis. Diabetes Care. 31(12): 2398-403.
3. de Groot M, Anderson R, Freedland KE, Clouse RE, Lustman PJ (2001) Association of depression and diabetes complications: a meta-analysis. Psychosom Med. 63(4): 619-30.
4. Bruce DG, Davis WA, Starkstein SE, Davis TM (2005) A prospective study of depression and mortality in patients with type 2 diabetes: the Fremantle Diabetes Study. Diabetologia 48(12): 2532-9.
5. Markowitz SM, Gonzalez JS, Wilkinson JL, Safren SA (2011) A review of treating depression in diabetes: emerging findings. Psychosomatics 1; 52(1): 1- 18.
6. Atlantis E, Goldney RD, Eckert KA, Taylor AW, Phillips P (2012) Trends in health-related quality of life and health service use associated with comorbid diabetes and major depression in South Australia, 1998-2008. Social psychiatry and psychiatric epidemiology 47(6): 871-7.
7. Atlantis E, Fahey P, Foster J (2014) Collaborative care for comorbid depression and diabetes: a systematic review and meta-analysis. BMJ open 4(4): e004706.
8. Egede LE, Ellis C (2010) Diabetes and depression: global perspectives. Diabetes research and clinical practice 87(3): 302-12.
9. Campayo A, Gomez-Biel CH, Lobo A (2011) Diabetes and depression. Current psychiatry reports 13(1): 26-30.
10. Atlantis E, Vogelzangs N, Cashman K, Penninx BJ (2012) Common mental disorders associated with 2-year diabetes incidence: the Netherlands Study of Depression and Anxiety (NESDA). J Affect Disord 142 Suppl: S30-5.
11. Kessler RC, Merikangas KR, Wang PS (2007) Prevalence, comorbidity, and service utilization for mood disorders in the United States at the beginning of the twenty-first century. Annual review of clinical psychology 3: 137-58.
12. Collins MM, Corcoran P, Perry IJ (2009) Anxiety and depression symptoms in patients with diabetes. Diabet Med 26(2): 153-61.
13. Edwards LE, Mezuk B (2012) Anxiety and risk of type 2 diabetes: evidence from the Baltimore Epidemiologic Catchment Area Study. J Psychosom Res 73(6): 418-23.
14. Nutt D, Argyropoulos S, Hood S, Potokar J (2006) Generalized anxiety disorder: A comorbid disease. European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology 16 Suppl 2: S109-18.
15. Davis TM, Bruce DG, Davis WA (2013) Cohort profile: the Fremantle Diabetes Study. Int J Epidemiol 42(2): 412-21.
16. Roy T, Lloyd CE, Pouwer F, Holt RI, Sartorius N (2012) Screening tools used for measuring depression among people with Type 1 and Type 2 diabetes: a systematic review. Diabet Med 29(2): 164-75.
17. Kroenke K, Spitzer RL, Williams JB (2001) The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 16(9): 606-13.
18. Kroenke K, Strine TW, Spitzer RL, Williams JB, Berry JT (2009) The PHQ-8 as a measure of current depression in the general population. J Affect Disord 114(1-3): 163-73.
19. Kroenke K, Spitzer RL, Williams JB, Lowe B (2010) The Patient Health Questionnaire Somatic, Anxiety, and Depressive Symptom Scales: a systematic review. Gen Hosp Psychiatry 32(4): 345-59.
20. Bruce DG, Davis WA, Cetrullo V, Starkstein SE, Davis TM (2013) Clinical Impact of the Temporal Relationship between Depression and Type 2 Diabetes: The Fremantle Diabetes Study Phase II. PLoS One 8(12): e81254.
21. Vermunt JK, Magidson J (2005) Technical Guide for Latent GOLD Choice 4.0: Basic and Advanced. Belmont, Massachussetts.
22. Ruscio J, Brown TA, Meron Ruscio A (2009) A taxometric investigation of DSM-IV major depression in a large outpatient sample: interpretable structural results depend on the mode of assessment. Assessment 16(2): 127-44.
23. Fisher L, Gonzalez JS, Polonsky WH (2014) The confusing tale of depression and distress in patients with diabetes: a call for greater clarity and precision. Diabet Med 31(7): 764-72.
24. Cyranowski JM, Schott LL, Kravitz HM, Brown C, Thurston RC, et al (2012) Psychosocial features associated with lifetime comorbidity of major depression and anxiety disorders among a community sample of mid-life women: the SWAN mental health study. Depress Anxiety 29(12): 1050-7.
25. Starr LR, Davila J (2012) Responding to Anxiety with Rumination and Hopelessness: Mechanism of Anxiety-Depression Symptom Co-Occurrence? Cognitive therapy and research 36(4): 321-37.
26. Fisher L, Skaff MM, Mullan JT, Arean P, Mohr D, et al. (2007) Clinical depression versus distress among patients with type 2 diabetes: not just a question of semantics. Diabetes Care 30(3): 542-8.